| Literature DB >> 26795251 |
Nicholas A Gherardin1, Andrew N Keller2, Rachel E Woolley2, Jérôme Le Nours2, David S Ritchie3, Paul J Neeson4, Richard W Birkinshaw2, Sidonia B G Eckle5, John N Waddington6, Ligong Liu7, David P Fairlie7, Adam P Uldrich6, Daniel G Pellicci6, James McCluskey5, Dale I Godfrey8, Jamie Rossjohn9.
Abstract
A characteristic of mucosal-associated invariant T (MAIT) cells is the expression of TRAV1-2(+) T cell receptors (TCRs) that are activated by riboflavin metabolite-based antigens (Ag) presented by the MHC-I related molecule, MR1. Whether the MR1-restricted T cell repertoire and associated Ag responsiveness extends beyond these cells remains unclear. Here, we describe MR1 autoreactivity and folate-derivative reactivity in a discrete subset of TRAV1-2(+) MAIT cells. This recognition was attributable to CDR3β loop-mediated effects within a consensus TRAV1-2(+) TCR-MR1-Ag footprint. Furthermore, we have demonstrated differential folate- and riboflavin-derivative reactivity by a diverse population of "atypical" TRAV1-2(-) MR1-restricted T cells. We have shown that TRAV1-2(-) T cells are phenotypically heterogeneous and largely distinct from TRAV1-2(+) MAIT cells. A TRAV1-2(-) TCR docks more centrally on MR1, thereby adopting a markedly different molecular footprint to the TRAV1-2(+) TCR. Accordingly, diversity within the MR1-restricted T cell repertoire leads to differing MR1-restricted Ag specificity.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26795251 DOI: 10.1016/j.immuni.2015.12.005
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745